Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + HDFL in Advanced Biliary Tract Cancer
NCT00201305Phase 2Completed
- Sponsor
- National Health Research Institutes
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in biliary tract cancer (BTC), sponsored by National Health Research Institutes. Started Jul 2002; status: completed.
02
Drugs
gemcitabine
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00201305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201305.